MX2024005206A - Proteína de la albúmina para uso emulsionante y portador de fármacos. - Google Patents

Proteína de la albúmina para uso emulsionante y portador de fármacos.

Info

Publication number
MX2024005206A
MX2024005206A MX2024005206A MX2024005206A MX2024005206A MX 2024005206 A MX2024005206 A MX 2024005206A MX 2024005206 A MX2024005206 A MX 2024005206A MX 2024005206 A MX2024005206 A MX 2024005206A MX 2024005206 A MX2024005206 A MX 2024005206A
Authority
MX
Mexico
Prior art keywords
emulsifier
drug carrier
albumin
albumin protein
carrier use
Prior art date
Application number
MX2024005206A
Other languages
English (en)
Spanish (es)
Inventor
Arthur Jaffee
Dan Schulz
Original Assignee
ECS Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ECS Holdings LLC filed Critical ECS Holdings LLC
Publication of MX2024005206A publication Critical patent/MX2024005206A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2024005206A 2021-10-26 2022-10-26 Proteína de la albúmina para uso emulsionante y portador de fármacos. MX2024005206A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163272088P 2021-10-26 2021-10-26
PCT/US2022/047934 WO2023076425A1 (en) 2021-10-26 2022-10-26 Albumin protein for use as an emulsifier and drug carrier

Publications (1)

Publication Number Publication Date
MX2024005206A true MX2024005206A (es) 2024-09-23

Family

ID=86158481

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005206A MX2024005206A (es) 2021-10-26 2022-10-26 Proteína de la albúmina para uso emulsionante y portador de fármacos.

Country Status (8)

Country Link
US (1) US20250009673A1 (https=)
EP (1) EP4422600A4 (https=)
JP (1) JP2024538322A (https=)
CN (1) CN118574604A (https=)
AU (1) AU2022376283A1 (https=)
CA (1) CA3236501A1 (https=)
MX (1) MX2024005206A (https=)
WO (1) WO2023076425A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3311805T (lt) * 2005-08-31 2020-04-27 Abraxis Bioscience, Llc Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus
AU2012280935A1 (en) * 2011-11-10 2013-05-30 Clover Corporation Limited Encapsulation of food ingredients supplements and pharmaceuticals
US20150079235A1 (en) * 2012-03-16 2015-03-19 Jennifer Wright Hemp-Based Infant Formula and Methods of Making Same
WO2019213757A1 (en) * 2018-05-07 2019-11-14 POS Management Corp. Hemp protein and use for microencapsulation
EP3937912A4 (en) * 2019-03-13 2022-12-21 Ulagaraj Selvaraj STABILIZED SOLID NANOPARTICLE FORMULATIONS OF CANNABINOIDS AND CANNABINOID ANALOGUES WITH REDUCED OSTWALD MATURATION FOR ORAL, INHALATIVE, NASAL AND PARENTAL DELIVERY
ES2944721T3 (es) * 2019-09-23 2023-06-23 Unilever Ip Holdings B V Emulsión de aceite en agua que comprende proteína vegetal
WO2021137225A1 (en) * 2020-01-02 2021-07-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Floating drug delivery systems comprising cannabinoids

Also Published As

Publication number Publication date
EP4422600A4 (en) 2025-12-10
JP2024538322A (ja) 2024-10-18
CN118574604A (zh) 2024-08-30
EP4422600A1 (en) 2024-09-04
AU2022376283A1 (en) 2024-06-13
WO2023076425A1 (en) 2023-05-04
US20250009673A1 (en) 2025-01-09
CA3236501A1 (en) 2023-05-04

Similar Documents

Publication Publication Date Title
CL2020002024A1 (es) Moduladores de calpaínas y usos terapeuticos de los mismos. (divisional solicitud 201900793)
UA130113C2 (uk) Мутеїн інтерлейкіну-21
CO2019002609A2 (es) Proteínas de unión recombinantes y sus usos
BR112013003361B8 (pt) Anticorpo, composição, conjugado de anticorpo,formulação farmacêutica e uso do anticorpo
CL2021001794A1 (es) Péptido, ácido nucleico, célula, composición farmacéutica, linfocito t activado, agente de unión aislado, y tcr, para su uso en inmunoterapia contra el cáncer; y métodos para producirlos (divisional de la solicitud no. 201600227)
BR112018074463A2 (pt) anticorpos anti-tim-3 e métodos de uso dos mesmos.
UY37463A (es) Proteínas de unión
BR112022027028A2 (pt) Composições para aumentar a meia-vida de um agente terapêutico em felinos e métodos de uso
MX2018005063A (es) Polipéptidos condicionalmente activos.
MY202248A (en) Interleukin-2 muteins for the expansion of t-regulatorv cells
BR112012022223A8 (pt) Formulação de proteína concentrada, uso e método de preparação da mesma
BR112019002127A2 (pt) proteína de fusão, vetor, célula, composição farmacêutica, e, uso da proteína de fusão
DE602004031301D1 (de) Nichtsymmetrisches geliermittel
DE50306384D1 (de) Mikro-emulsionen mit binärer phasen- und wirkstoffdifferenzierbarkeit, deren herstellung und deren verwendung, insbesondere zur topischen sauerstoffversorgung
EA201892396A1 (ru) Быстродействующие растительные лекарственные соединения и биологически активные добавки
BR112015022148A2 (pt) combinações de substâncias ativas; preparações cosméticas ou dermatológicas; uso cosmético não terapêutico de preparações ou de combinações de substâncias ativas; e combinações de substâncias ativas e preparações
BR112023019138A2 (pt) Proteína multiespecífica, composição farmacêutica, célula recombinante, método de preparação de uma composição de célula nk, composição de células nk, uso de uma proteína ou composição, métodos e uso
MX2020006635A (es) Proteína de fusión enzimática terapéutica que tiene una nueva estructura y uso de la misma.
JP2019517533A5 (https=)
MX2018008467A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
ECSP21060917A (es) Formulación de anticuerpos terapéuticos
EA201190134A1 (ru) Трансдермальные фармацевтические препараты
BR112018075222A2 (pt) anticorpos anti-tnfrsf25
EA200602137A1 (ru) Гидрогелевые препараты интерферона
BR112016013322A2 (pt) Métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit